Qiagen N.V. income statement

In fiscal 2025, Qiagen N.V. reported revenue of $2.09bn, up 5.7% on the year before, operating income of $466m (a 22.3% margin) and net income of $425m, or $1.94 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Qiagen N.V.: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	1,010	1,087	1,170	1,254	1,302	1,345	1,281	1,338	1,418	1,502	1,526	1,870	2,252	2,142	1,965	1,978	2,090
Cost of revenue	—	—	—	—	—	—	—	493	495	501	521	638	801	757	732	1,011	791
Gross profit	667	716	750	824	815	865	827	845	923	1,001	1,005	1,233	1,451	1,385	1,234	967	1,299
Research and development	108	126	131	122	146	164	147	150	154	162	157	149	190	190	199	193	188
Selling and marketing	245	267	307	344	372	376	360	376	376	392	392	414	456	474	460	451	458
General and administrative	—	—	—	—	—	—	—	—	102	105	112	112	128	130	119	113	126
Operating income	180	189	100	170	63	162	179	99	153	267	−26	386	630	531	410	98	466
Interest expense	30	28	25	23	31	39	37	39	50	67	74	71	54	58	53	44	33
Provision for credit losses	—	—	—	—	—	—	—	—	—	—	—	1	2	6	0	−0	0
Income before tax	172	173	96	145	37	119	136	57	114	226	−78	439	626	513	430	121	490
Income tax	35	29	1	16	−32	2	6	−23	74	35	−36	80	113	89	89	38	65
Net income	138	144	96	130	69	116	130	80	40	190	−41	359	513	423	341	84	425
Diluted EPS	$0.64	$0.60	$0.40	$0.54	$0.29	$0.48	$0.55	$0.34	$0.17	$0.82	−$0.18	$1.53	$2.21	$1.84	$1.48	$0.37	$1.94
Diluted shares (average)	214m	240m	239m	241m	242m	243m	239m	239m	233m	233m	227m	234m	232m	230m	231m	225m	219m
EBITDA	229	331	267	368	263	362	371	312	370	473	205	591	845	740	615	301	660

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BIO vs QGEN FTRE vs QGEN MEDP vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Qiagen N.V.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Qiagen N.V.